Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

PERRIGO COMPANY (PRGO)
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2018 5 056 M
EBIT 2018 1 062 M
Net income 2018 392 M
Debt 2018 2 118 M
Yield 2018 0,81%
Sales 2019 5 235 M
EBIT 2019 1 118 M
Net income 2019 529 M
Debt 2019 1 369 M
Yield 2019 0,86%
P/E ratio 2018 28,27
P/E ratio 2019 20,98
EV / Sales2018 2,69x
EV / Sales2019 2,46x
Capitalization 11 487 M
More Financials
Company
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products.It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals.The... 
Sector
Pharmaceuticals
Calendar
05/04 | 12:00pmShareholder meeting
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
04/16PERRIGO : Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Freque..
AQ
04/13PERRIGO COMPANY PLC : Free Post Earnings Research Report: Perrigo Co.'s Quarterl..
AC
04/11PERRIGO : Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Freque..
PR
04/10IMPAX LABORATORIES : Launches a Generic Version of Estrace Cream
AQ
03/16PERRIGO : CHPA - John Hendrickson Receives the Industry's Highest Honor the Ivan..
AQ
03/15PERRIGO : Announces Final FDA Approval and Planned Launch for the Store Brand OT..
AQ
03/12PERRIGO : Announces Final FDA Approval and Planned Launch for the Store Brand OT..
AQ
03/12PERRIGO : to Present at Upcoming Investor Conferences
AQ
03/09PERRIGO CO PLC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
03/07PERRIGO : Announces Final FDA Approval and Planned Launch for the Store Brand OT..
PR
More news
Sector news : Pharmaceuticals - NEC
08:48aTAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
More sector news : Pharmaceuticals - NEC
Chart PERRIGO COMPANY
Duration : Period :
Perrigo Company Technical Analysis Chart | PRGO | US7142901039 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 93,1 $
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Uwe Röhrhoff President, Chief Executive Officer & Director
Mary Lauren Brlas Chairman
Ronald Janish Executive VP-Global Operations and Supply Chain
Ron L. Winowiecki Chief Financial Officer
Thomas Farrington Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY11 487
JOHNSON & JOHNSON-8.71%339 783
PFIZER0.86%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571